Requires clinical trial sponsors in New York to post specific trial information on the department's website if they apply for a state grant.

This bill mandates that any sponsor of a clinical trial in New York, including pharmaceutical drug manufacturers, academic medical centers, and health care providers, must post certain information about the trial on the department's website if they apply for a state grant. The information includes the therapeutic intent, sponsors, criteria, treatment methods, hypotheses, start and end dates, and potential adverse effects. The commissioner is tasked with ensuring compliance and monitoring the website for adherence to these requirements.

Requires clinical trial sponsors in New York to post specific trial information on the department's website if they apply for a state grant.

This bill mandates that any sponsor of a clinical trial in New York, including pharmaceutical drug manufacturers, academic medical centers, and health care providers, must post certain information about the trial on the department's website if they apply for a state grant. The information includes the therapeutic intent, sponsors, criteria, treatment methods, hypotheses, start and end dates, and potential adverse effects. The commissioner is tasked with ensuring compliance and monitoring the website for adherence to these requirements.